echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > EU ban on traditional Chinese Medicine

    EU ban on traditional Chinese Medicine

    • Last Update: 2011-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Business club, May 9 - the EU registration procedure directive for traditional botanical drugs, which came into effect in 2004, ended the transition period on May 1, 2011 and began to be officially implemented Unregistered traditional Chinese medicine will not be allowed to be sold and used in the EU market Seven years later, no Chinese medicine enterprise has been registered What is the crux? Influence geometry? How variable is the position of traditional Chinese medicine in the international market? In the industry, the export of traditional Chinese medicine is unknown On March 31, 2004, the European Union passed the directive on the registration procedure of traditional botanical medicine, which allows the herbal medicine products that have been sold as "dietary supplements" in the EU market to be sold for another 7 years, and during this period allows the use of simplified application of traditional herbal medicine to obtain the legal status of drugs However, 7 years later, no Chinese medicine has been successfully registered in Europe So, is there any political factor in the encounter of traditional Chinese medicine in Europe? Is the European Union, which takes western medicine as the orthodox medicine, deliberately difficult to make traditional Chinese medicine? Recommend reading food industry, train moral and ethical adults, eat nearly 100 kinds of additives a day, interview with national development and Reform Commission, 6 ocean milk powder, Guangzhou Metro renovation project, suspected of burning money lake, Nantes, large lean meat powder case, involving an amount of 30 million, Shanxi coal boss, three adults, invest in Internet vendors, pour chicken with barite powder, increase weight, fund manager, why does Mom's investment income far exceed that of him [application] listen to the good opportunity of cultural and national day to teach you to copy the bottom General election needs? According to some analysis, there is a competitive relationship between Chinese patent medicine and Western medicine At present, many European countries are facing general election In order to attract Western medicine forces, the government may run on traditional Chinese medicine Frank duszhe, a senior executive of a European bank, said that Chinese in the EU should be more involved in local politics Turks and other immigrants from various countries have entered the Dutch government, and so should Chinese "When you are involved in Dutch politics, you can get involved in the field of medicine and participate in rulemaking." Colored glasses? It is understood that the people who were in charge of drafting the registration procedure instruction of traditional botanical medicine were basically from the background of Western medicine, and they knew little about traditional Chinese medicine Wearing "colored glasses" of Western medicine to set rules for traditional Chinese medicine naturally "does not fit" What they are concerned about is only European herbal medicine Compared with traditional Chinese medicine, European herbal medicine has a larger market share, but it is far less complicated than traditional Chinese medicine As a result, the final "directive" makes traditional Chinese medicine "acclimatized" According to the relevant documents, the registration requirements in the directive are not suitable for traditional Chinese medicine and Indian herbal medicine Due to the lack of time and funds to find solutions, this problem has been left to Member States to solve by themselves In the process of EU legislation, China has not expressed concern, but the EU is not willing to listen, which highlights the lack of regulatory cooperation between the two sides European MP Pavel Burke believes that the directive is discriminatory He once said that he would bring a lawsuit to the high court of London, hoping to attract the attention of the European Court in Luxembourg The dispute of interests? Robert Cato, President of the Italian Association of traditional Chinese medicine, said in an interview with Xinhua News Agency recently that it is necessary for the EU to reconsider the legislation of traditional plant medicine and avoid excessive impact on traditional Chinese medicine and other foreign traditional medicine industries He said that authoritative research has confirmed that traditional plant medicine, especially traditional Chinese medicine, can combine with western medicine and has good curative effect "Unfortunately, the concept of traditional Chinese medicine is not well known by Europeans, and governments of EU countries do not know enough about the situation of traditional medicine market." Cato said that EU governments have different policy scales on this issue, and the interests of large companies and different political opinions make this issue more complex and delicate, which makes many enterprises and patients at a loss He called on EU member governments to work together to explore ways to develop traditional Chinese medicine and further strengthen exchanges between universities and scientific research institutions on traditional Chinese medicine Some scholars think that the directive issued by the EU is actually a disguised trade barrier In 2010, China also negotiated with the EU on this issue at the level of WTO, but the response of the EU has always been: "this registration and sales regulation is not considered as a trade barrier, and traditional Chinese medicine is welcome to enter the EU market." However, it has been an open practice in Europe and America to set up trade barriers under the pretext of security In recent years, the United States, Japan and other countries have put forward new registration requirements for health products and plant extracts, and the importing countries have raised higher requirements for the production technology and product quality of traditional Chinese medicine extracts In 2011, traditional Chinese medicine enterprises will encounter multiple resistance of technical barriers in many major markets, and the export of traditional Chinese medicine is likely to be in trouble.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.